CMS certification 493301
Childrens Hospital of the Kings Daughters INC
601 Children's Lane, Norfolk, VA 23507
This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: Oct 2024 – Sep 2025.
Not reported for this hospital
CMS had too few cases here to publish results for deaths, complications, infections caught in the hospital, readmissions and return visits. That is common at small, rural and specialty hospitals, and says nothing either way about quality.
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $113,098
- 2020 $85,838
- 2021 $301,611
- 2022 $366,829
- 2023 $56,848
- 2024 $171,110
- 2025 $79,943
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Speaking, teaching and other services | $55,875 | 47 |
| Education | $106 | 1 |
| Charitable contributions | $25 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Insulet Corporation | $41,125 | 20 |
| Pfizer INC. | $13,000 | 3 |
| Tandem Diabetes Care, Inc. | $12,500 | 19 |
| Jazz Pharmaceuticals INC. | $5,576 | 1 |
| Biogen, Inc. | $4,134 | 2 |
| Medtronic, Inc. | $2,175 | 7 |
| Incyte Corporation | $1,000 | 1 |
| E.R. Squibb & Sons, L.L.C. | $228 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A PHASE 23 RANDOMIZED MULTICENTER STUDY OF GBT021601 ADMINISTERED ORALLY TO PARTICIPANTS WITH SICKLE CELL DISEASE AND AN OPENLABEL PHARMACOKINETICS S… PFIZER INC. | $9,500 |
| ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-C… JAZZ PHARMACEUTICALS INC. | $5,576 |
| PHASE 12 STUDY TO EVALUATE PALBOCICLIB IBRANCE IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE OR IN COMBINATION WITH TOPOTECAN AND CYCLOPHOSPHAMIDE … PFIZER INC. | $3,500 |
| A Phase 3b Study to Evaluate Higher Dose Nusinersen (BIIB058) in Patients with Spinal Muscular Atrophy Previously Treated with Risdiplam Biogen, Inc. | $2,765 |
| A Phase 4 Study of Nusinersen (BIIB058) Among Patients With Spinal Muscular Atrophy Who Received Onasemnogene Abeparvovec Biogen, Inc. | $1,369 |
| A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearranged and or JAK Pathway Muta… Incyte Corporation | $1,000 |
| A Phase 1/2 Study of the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adult Pa… E.R. Squibb & Sons, L.L.C. · NCT05255601 | $228 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Childrens Hospital of the Kings Daughters
Does Childrens Hospital of the Kings Daughters have an emergency room?
Yes. CMS lists emergency services at Childrens Hospital of the Kings Daughters.
Does Childrens Hospital of the Kings Daughters receive money from drug and device companies?
Drug and device makers reported $79,943 in payments to Childrens Hospital of the Kings Daughters for 2025, under the federal Open Payments program. A payment on its own does not show a conflict of interest.